260 related articles for article (PubMed ID: 21251330)
1. Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.
Mao JJ; Su HI; Feng R; Donelson ML; Aplenc R; Rebbeck TR; Stanczyk F; DeMichele A
Breast Cancer Res; 2011 Jan; 13(1):R8. PubMed ID: 21251330
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors.
Romero SAD; Su HI; Satagopan J; Li QS; Seluzicki CM; Dries A; DeMichele AM; Mao JJ
Breast; 2020 Feb; 49():48-54. PubMed ID: 31678641
[TBL] [Abstract][Full Text] [Related]
3. Randomized Controlled Trial of a Home-Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors.
Nyrop KA; Callahan LF; Cleveland RJ; Arbeeva LL; Hackney BS; Muss HB
Oncologist; 2017 Oct; 22(10):1238-1249. PubMed ID: 28698390
[TBL] [Abstract][Full Text] [Related]
4. Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias.
Galantino ML; Desai K; Greene L; Demichele A; Stricker CT; Mao JJ
Integr Cancer Ther; 2012 Dec; 11(4):313-20. PubMed ID: 21733988
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients.
Gervasini G; Jara C; Olier C; Romero N; Martínez R; Carrillo JA
Br J Clin Pharmacol; 2017 Mar; 83(3):562-571. PubMed ID: 27747906
[TBL] [Abstract][Full Text] [Related]
6. Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients.
Borrie AE; Rose FA; Choi YH; Perera FE; Read N; Sexton T; Lock M; Vandenberg TA; Hahn K; Younus J; Logan D; Potvin K; Yaremko B; Yu E; Lenehan J; Welch S; Teft WA; Kim RB
Breast Cancer Res Treat; 2020 Sep; 183(2):365-372. PubMed ID: 32632513
[TBL] [Abstract][Full Text] [Related]
7. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors.
Mao JJ; Stricker C; Bruner D; Xie S; Bowman MA; Farrar JT; Greene BT; DeMichele A
Cancer; 2009 Aug; 115(16):3631-9. PubMed ID: 19517460
[TBL] [Abstract][Full Text] [Related]
8. A qualitative exploration of the impact of yoga on breast cancer survivors with aromatase inhibitor-associated arthralgias.
Galantino ML; Greene L; Archetto B; Baumgartner M; Hassall P; Murphy JK; Umstetter J; Desai K
Explore (NY); 2012; 8(1):40-7. PubMed ID: 22225932
[TBL] [Abstract][Full Text] [Related]
9. Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: a feasibility study.
Galantino ML; Callens ML; Cardena GJ; Piela NL; Mao JJ
Altern Ther Health Med; 2013; 19(6):38-44. PubMed ID: 24254037
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER + breast cancer.
Napoli N; Rastelli A; Ma C; Yarramaneni J; Vattikutti S; Moskowitz G; Giri T; Mueller C; Kulkarny V; Qualls C; Ellis M; Armamento-Villareal R
Bone; 2013 Aug; 55(2):309-14. PubMed ID: 23643682
[TBL] [Abstract][Full Text] [Related]
11. Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.
Brier MJ; Chambless DL; Chen J; Mao JJ
Eur J Cancer; 2018 Mar; 91():145-152. PubMed ID: 29329697
[TBL] [Abstract][Full Text] [Related]
12. Feasibility trial of electroacupuncture for aromatase inhibitor--related arthralgia in breast cancer survivors.
Mao JJ; Bruner DW; Stricker C; Farrar JT; Xie SX; Bowman MA; Pucci D; Han X; DeMichele A
Integr Cancer Ther; 2009 Jun; 8(2):123-9. PubMed ID: 19679620
[TBL] [Abstract][Full Text] [Related]
13. Aromatase inhibitor associated musculoskeletal symptoms are associated with reduced physical activity among breast cancer survivors.
Brown JC; Mao JJ; Stricker C; Hwang WT; Tan KS; Schmitz KH
Breast J; 2014; 20(1):22-8. PubMed ID: 24165356
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with body composition changes in women on aromatase inhibitors for ER (+) breast cancer.
Napoli N; Rastelli A; Ma C; Colleluori G; Vattikuti S; Armamento-Villareal R
Pharmacogenet Genomics; 2015 Aug; 25(8):377-81. PubMed ID: 26049585
[TBL] [Abstract][Full Text] [Related]
15. Aromatase inhibitor-associated arthralgia syndrome.
Burstein HJ
Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
[TBL] [Abstract][Full Text] [Related]
16. Joint pain and falls among women with breast cancer on aromatase inhibitors.
Basal C; Vertosick E; Gillis TA; Li Q; Bao T; Vickers A; Mao JJ
Support Care Cancer; 2019 Jun; 27(6):2195-2202. PubMed ID: 30306326
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients.
Ferraldeschi R; Arnedos M; Hadfield KD; A'Hern R; Drury S; Wardley A; Howell A; Evans DG; Roberts SA; Smith I; Newman WG; Dowsett M
Breast Cancer Res Treat; 2012 Jun; 133(3):1191-8. PubMed ID: 22418701
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy.
Nyrop KA; Muss HB; Hackney B; Cleveland R; Altpeter M; Callahan LF
J Geriatr Oncol; 2014 Apr; 5(2):148-55. PubMed ID: 24495696
[TBL] [Abstract][Full Text] [Related]
19. Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm.
Reinbolt RE; Sonis S; Timmers CD; Fernández-Martínez JL; Cernea A; de Andrés-Galiana EJ; Hashemi S; Miller K; Pilarski R; Lustberg MB
Cancer Med; 2018 Jan; 7(1):240-253. PubMed ID: 29168353
[TBL] [Abstract][Full Text] [Related]
20. Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.
Castel LD; Hartmann KE; Mayer IA; Saville BR; Alvarez J; Boomershine CS; Abramson VG; Chakravarthy AB; Friedman DL; Cella DF
Cancer; 2013 Jul; 119(13):2375-82. PubMed ID: 23575918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]